1984

Exmere founded

1985

Development of a Novel Aqueous Process for spherical Silica Spheres Independent Control of Pore Volume, Pore Diameter and Surface Area

Exsil Range:
·Pore Size: 60-1000Å
·Particle Size: 1.5-50 µm
·Pore Volume: 0.5-1.3 ml/g
·Surface Area: <500 m²/g
·Bonding: Extensive Range

1988

3 Micron Wide Pore Silica Gel

1990

Exsil 80 Alternative to Spherisorb

1993

Introduction of first commercially available sub2 micron Silica Gel worldwide (Exsil 100 ODS, 1.5 µm)

1995

Platinum Silica and EPS Bonding A unique diametric opposite to current RP18

1999

Avanti / Avanti BDS Alternative to Hypersil

2003

Exsil Pure High purity silica, RP18 and C18MS
GFC3000 Alternative to TSK G3000SW for protein SEC

2004

Exsil Polar P for Drugs in Serum

2005

Acquired by GRACE Alltech

2016

Split off from GRACE // Stand alone company Exmere Ltd. and Development of non-porous 1.5 µm Silica Phases in the same year

2017

Release of coated and immobilized Polysaccharide Phases as alternative to Daicel Chiralpak / Chiracel

2018

Development of 500Å pore size High Purity Silica gel for Rapid Analysis of Proteins and Peptides

2019

Developed and commercialized 1.0 um Silica gel with column efficiency exceeding 500,000 N/m

2020

Developed an ultra-high purity SenSil UHPLC columns

2021

Development of Empowered CapaSil HPLC columns

2022

Development of Omics sample preparation kits, named as PreciEx